Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYour second dose of Mounjaro is taken one week after your first, using the same injection technique. The pen is unchanged; what changes is that your body is slightly more accustomed to the medicine. Most people find that side effects, if they had any in week one, begin to ease from the second dose onwards. Mounjaro is a prescription-only medicine, and your prescriber sets your personal schedule, so the guidance here is educational rather than a substitute for their instructions or the Patient Information Leaflet supplied with your pen.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Many people starting Mounjaro assume the second dose means stepping up to 5 mg. It does not. The 2.5 mg starting dose is designed to run for at least four weeks, giving your system time to adjust to tirzepatide before any increase is considered. Your second injection is still 2.5 mg, drawn from the same KwikPen you started with.
Each Mounjaro KwikPen contains four doses, each of 2.5 mg. So the pen you opened for your very first injection is the same pen you use for your second, third and fourth. You do not open a new pen on week two. This surprises a lot of people, and it is worth being clear on before you reach into the fridge.
The reason the starting dose is held at 2.5 mg for several weeks has nothing to do with effectiveness and everything to do with tolerability. Tirzepatide slows gastric emptying and acts on two gut-hormone receptors simultaneously. Introducing it gradually gives your digestive system a chance to adapt. Our clinical team at nume reviews each patient's progress before any dose change is approved, dose increases are a clinical decision, not an automatic calendar event.
If you are curious about what the 5 mg phase looks like when the time comes, our guide on moving to the 5 mg dose of Mounjaro covers the transition in detail.
The most practical thing to get right from week two onwards is consistency. Mounjaro works best when doses are spaced as close to seven days apart as possible. If your first injection was on a Wednesday evening, your second should fall on Wednesday again.
Life being what it is, you may not always hit the exact hour. Missing by a day is generally manageable, but your prescriber and the Patient Information Leaflet are the right places to check for guidance on what to do if you are significantly late. We do not give missed-dose instructions here because the right answer depends on your specific situation.
Choosing a day that fits your routine genuinely helps. Some people find a weekday morning works well, the 12pm cut-off for same-day dispatch at most clinical services creates a natural anchor around the middle of the day. Others prefer a Sunday so the first day or two of any adjustment coincides with time at home. There is no clinically superior day; it is whichever one you will remember reliably.
For a detailed look at exactly how to handle the pen itself on your second injection, the step-by-step injection guide for the second Mounjaro dose walks through site selection, needle placement and post-injection care.
For many people, week two is quieter than week one. The nausea, loose stools or burping that can accompany the first dose often soften as the body acclimatises. That said, everyone's response is individual. Some people notice very little at any point; others find side effects more noticeable in the first fortnight before they settle.
Common effects in the early weeks are gastrointestinal: nausea, constipation, diarrhoea, indigestion and fatigue are the ones most often reported. The NHS medicines page for tirzepatide lists side effects in full, including which ones warrant medical attention. On that point: severe, persistent stomach pain that radiates to the back needs prompt assessment, as it can be a sign of pancreatitis. Contact a clinician or call 111 if that happens.
Appetite reduction is also likely to become more noticeable across the first few weeks. Eating slowly, prioritising protein and staying well hydrated all support the process. Your prescriber is the right person to talk to if side effects feel unmanageable or if you are unsure whether what you are experiencing is expected.
If you have questions about how Mounjaro works as a treatment, the Mounjaro overview page covers the mechanism, the licensed evidence and what clinical supervision involves.
Your second dose coming from the same pen means you do not need a repeat prescription at week two. The pen holds four weekly doses, so a single pen covers your first month of treatment. When you approach the end of that pen, a repeat prescription is needed, and at that point your prescriber will review your progress before issuing it.
At nume, that review happens before every repeat order. A prescriber reads your update, not an automated system. Understanding what comes next at each stage, including what the 5 mg pen involves when the time arrives, is part of the guidance on the 2.5 mg starting phase and in our broader treatment overview.
If you are considering starting Mounjaro and want to understand costs before committing, our guide on accessing Mounjaro through a regulated UK pharmacy covers what a legitimate private prescription involves. For those wondering how doses are determined individually, this page on Mounjaro dosing decisions sets out the clinical thinking behind titration.
For questions not covered here, our FAQs address common queries, or you can get in touch with our clinical support team directly.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.